OS Therapies Inc (OSTX) Form 8-K — Oct 19, 2026
OS Therapies (NYSE American: OSTX) completed an initial closing on October 15, 2026 of a warrant exercise inducement offer, with seven of nine invited holders exercising or pre-funding warrants to purchase 5,517,253 shares at a reduced $1.30 per share, generating approximately $7.2 million in gross proceeds. In exchange, the company issued new five-year warrants for the same 5.5 million shares at a $1.40 exercise price; if all remaining existing warrants are exercised by the October 30 expiration, total gross proceeds could reach approximately $12.3 million and new warrants would cover up to 9,448,060 shares. Management says proceeds plus $7 million in accrued refundable U.K.
Key figures
- Most Recent PRVSale
- 203000000
- New Warrants Issued Max
- 9448060
- Existing Warrant Shares
- 9448060
- R And DTax Credits Accrued
- 7000000
- Inducement Exercise Price
- 1.3
- New Warrant Exercise Price
- 1.4
- Solicitation Agent Fee Pct
- 7.0%
- Gross Proceeds Initial Closing
- 7200000
- Gross Proceeds Full Subscription
- 12300000
- Shares Exercised Initial Closing
- 5517253
- Solicitation Agent Expense Allowance
- 25000
- Warrant Term
- 5 years
- Holders Offered
- 9
- Offer Expiration
- 2026-10-30
- Forced Exercise Trigger
- 300% of exercise price for 20 consecutive trading days
- Holders Exercised Initial Closing
- 7
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.